{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:27:08Z","timestamp":1790634428359,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"No Funding available"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12882-016-0325-4","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T08:49:18Z","timestamp":1470214158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Proton pump inhibitors are associated with increased risk of development of chronic kidney disease"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-7620","authenticated-orcid":false,"given":"Pradeep","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Golzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilang","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"key":"325_CR1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1756283X12437358","volume":"5","author":"J Heidelbaugh","year":"2012","unstructured":"Heidelbaugh J, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therapy Adv Gastroenterol. 2012;5:219\u201332.","journal-title":"Therapy Adv Gastroenterol"},{"key":"325_CR2","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s10620-009-1004-0","volume":"55","author":"FK Friedenberg","year":"2010","unstructured":"Friedenberg FK, Hanlon A, Vanar V, Nehemia D, Mekapati J, Nelson DB, et al. Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci. 2010;55:1911\u20137.","journal-title":"Dig Dis Sci"},{"key":"325_CR3","unstructured":"IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion. 2008. http:\/\/www.businesswire.com\/news\/home\/20080312005158\/en\/IMS-Health-Reports-U.S.-Prescription-Sales-Grew ."},{"key":"325_CR4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamainternmed.2013.2851","volume":"173","author":"M Maggio","year":"2013","unstructured":"Maggio M, Corsonello A, Ceda GP, Cattabiani C, Lauretani F, Butto V, et al. Proton Pump Inhibitors and Risk of 1-Year Mortality and hospitalization in older patients discharged from acute care hospitals. JAMA Intern Med. 2013;173:518\u201323.","journal-title":"JAMA Intern Med"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"d2690","DOI":"10.1136\/bmj.d2690","volume":"342","author":"M Charlot","year":"2011","unstructured":"Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, et al. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ. 2011;342:d2690. doi: 10.1136\/bmj.d2690 .","journal-title":"BMJ"},{"key":"325_CR6","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/archinternmed.2010.331","volume":"170","author":"JS Bell","year":"2010","unstructured":"Bell JS, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH. Use of proton pump inhibitors and mortality among institutionalized older people. Arch Intern Med. 2010;170:1604\u20135.","journal-title":"Arch Intern Med"},{"key":"325_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.ki.5002038","volume":"71","author":"UC Brewster","year":"2007","unstructured":"Brewster UC, Perazella MA. Acute kidney injury following proton pump inhibitor therapy. Kidney Int. 2007;71:589\u201393.","journal-title":"Kidney Int"},{"key":"325_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/biomet\/66.3.403","volume":"66","author":"RL Prentice","year":"1979","unstructured":"Prentice RL, Pyke R. Logistic Incidence Models and Case-Control Studies. Biometrika. 1979;66:403\u201311.","journal-title":"Biometrika"},{"key":"325_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/biomet\/59.1.19","volume":"59","author":"JA Anderson","year":"1972","unstructured":"Anderson JA. Separate sample logistic discrimination. Biometrika. 1972;59:19\u201335.","journal-title":"Biometrika"},{"key":"325_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2307\/2529594","volume":"34","author":"NE Breslow","year":"1978","unstructured":"Breslow NE, Powers W. Are there two logistic regressions for retrospective studies? Biometrics. 1978;34:100\u20135.","journal-title":"Biometrics"},{"key":"325_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5414\/CNP68065","volume":"68","author":"UC Brewster","year":"2007","unstructured":"Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Nephrol. 2007;68:65\u201372.","journal-title":"Clin Nephrol"},{"key":"325_CR12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","volume":"77","author":"M Praga","year":"2010","unstructured":"Praga M, Gonzalez E. Acute Interstitial nephritis. Kidney Int. 2010;77:956\u201361.","journal-title":"Kidney Int"},{"key":"325_CR13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1440-1797.2006.00651.x","volume":"11","author":"IJ Simpson","year":"2006","unstructured":"Simpson IJ, Marshall MR, Pilmore H, Manley P, William L, Thein H, et al. Proton pump inhibitor and acute interstitial nephritis: report and analysis of 15 cases. Nephrology (Carlton). 2006;11:381\u20135.","journal-title":"Nephrology (Carlton)"},{"key":"325_CR14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.2014.74","volume":"86","author":"ML Blank","year":"2014","unstructured":"Blank ML, Parkin L, Paul C, Herbison P. A nationwide nested case- control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int. 2014;86:837\u201344.","journal-title":"Kidney Int"},{"key":"325_CR15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cgh.2005.11.004","volume":"4","author":"N Geevasinga","year":"2006","unstructured":"Geevasinga N, Coleman PL, Webster AC, Roger SD. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol. 2006;4:597\u2013604.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"325_CR16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2036.2007.03407.x","volume":"26","author":"F Sierra","year":"2007","unstructured":"Sierra F, Suarez M, Rey M, Vela MF. Systematic review: proton pump inhibitor associated acute interstitial nephritis. Aliment Pharmacol Ther. 2007;26:545\u201353.","journal-title":"Aliment Pharmacol Ther"},{"key":"325_CR17","doi-asserted-by":"crossref","unstructured":"Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. J Am Soc Nephrol. 2016. [epub ahead of print].","DOI":"10.1681\/ASN.2015121377"},{"issue":"2","key":"325_CR18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, et al. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016;176(2):238\u201346.","journal-title":"JAMA Intern Med"},{"issue":"4 Suppl 1","key":"325_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0272-6386(00)70239-3","volume":"35","author":"MJ Sarnak","year":"2000","unstructured":"Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000;35(4 Suppl 1):117\u201331.","journal-title":"Am J Kidney Dis"},{"key":"325_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.abb.2006.03.031","volume":"458","author":"A Mazur","year":"2007","unstructured":"Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys. 2007;458:48\u201356.","journal-title":"Arch Biochem Biophys"},{"key":"325_CR21","first-page":"58","volume":"21","author":"FI Wolf","year":"2008","unstructured":"Wolf FI, Trapani V, Simonacci M, Ferr\u00e9 S, Maier JA. Magnesium deficiency and endothelial dysfunction: is oxidative stress involved? Magnes Res. 2008;21:58\u201364.","journal-title":"Magnes Res"},{"key":"325_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000013582","volume":"20","author":"A Corsonello","year":"2000","unstructured":"Corsonello A, Ientile R, Buemi M, Cucinotta D, Mauro VN, Macaione S, et al. Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol. 2000;20:187\u201392.","journal-title":"Am J Nephrol"},{"key":"325_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5414\/CNP63429","volume":"63","author":"PC Pham","year":"2005","unstructured":"Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM, et al. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol. 2005;63:429\u201336.","journal-title":"Clin Nephrol"},{"key":"325_CR24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc12-0226","volume":"35","author":"Y Sakaguchi","year":"2012","unstructured":"Sakaguchi Y, Shoji T, Hayashi T, Suzuki A, Shimizu M, Mitsumoto K, et al. Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease. Diabetes Care. 2012;35:1591\u20137.","journal-title":"Diabetes Care"},{"key":"325_CR25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1271\/bbb.66.192","volume":"66","author":"H Matsuzaki","year":"2002","unstructured":"Matsuzaki H, Ohdachi J, Fuchigami M, Masuyama R, Uehara M, Nakamura K, et al. Changes in N-acetyl-beta-D-glucosaminidase activity in the urine and urinary albumin excretion in magnesium deficient rats. Biosci Biotechnol Biochem. 2002;66:192\u20134.","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-016-0325-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:06:48Z","timestamp":1749024408000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-016-0325-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/s12882-016-0325-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726609441.793523530","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]},"article-number":"112"}}